Methods of treating neurodegenerative diseases or conditions
AssigneesFloraScience Inc., The Salk Institute for Biological Studies
InventorsRobert Paul Jensen, Pamela Maher, Zhibin Liang
Life of this patent
Estimating the term…
Abstract
Provided are methods of treating a neurodegenerative disease or condition in a subject in need thereof including administering a cannabinoid to the subject.
Claims45
A method of treating a neurodegenerative disease or condition in a subject, comprising administering a therapeutically effective amount of a cannabinoid to the subject.
(canceled)
18-19. (canceled)
26-32. (canceled)
(canceled)
37-38. (canceled)
A method of treating a disease or disorder associated with mitochondrial dysfunction associated with an aging brain in a subject, comprising administering a therapeutically effective amount of a cannabinoid to the subject.
43-69. (canceled)
A method of inhibiting oxytosis/ferroptosis in a subject, comprising administering a cannabinoid to the subject.
71-97. (canceled)
A method of protecting nerve cells from oxytosis/ferroptosis in a subject, comprising administering a cannabinoid to the subject.
99-126. (canceled)
A method of treating a neurodegenerative disease or condition in a subject, comprising administering a therapeutically effective amount of a cannabinoid to the subject, wherein the cannabinoid inhibits oxytosis/ferroptosis.
128-145. (canceled)
A method of treating a disease or disorder associated with mitochondrial dysfunction associated with an aging brain in a subject, comprising administering a therapeutically effective amount of a cannabinoid to the subject.
147-166. (canceled)
A method of protecting nerve cells from oxytosis/ferroptosis in a subject, comprising administering a cannabinoid to the subject.
168-188. (canceled)
Dependencies are inferred from the claim text.